Needham & Company Reiterates a 'Buy' on Lexicon Pharmaceuticals (LXRX); 2012 Preview: Several Key Clinical Milestones Anticipated
Go back to Needham & Company Reiterates a 'Buy' on Lexicon Pharmaceuticals (LXRX); 2012 Preview: Several Key Clinical Milestones Anticipated| Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) | Delayed: 2.34 +0.02 (0.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.32 | 52 Week High | $19.62 | |||
| Open | $2.31 | 52 Week Low | $7.65 | |||
| Day High | $2.39 | P/E | N/A | |||
| Day Low | $2.29 | EPS | $-0.22 | |||
| Volume | 3,530,414 | |||||
